CA1030960A - Nouveau compose therapeutique et utilisation - Google Patents

Nouveau compose therapeutique et utilisation

Info

Publication number
CA1030960A
CA1030960A CA215,984A CA215984A CA1030960A CA 1030960 A CA1030960 A CA 1030960A CA 215984 A CA215984 A CA 215984A CA 1030960 A CA1030960 A CA 1030960A
Authority
CA
Canada
Prior art keywords
same
novel compounds
therapeutic composition
compounds useful
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA215,984A
Other languages
English (en)
Other versions
CA215984S (en
Inventor
Paul Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alseres Pharmaceuticals Inc
Original Assignee
Strategic Medial Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/424,786 external-priority patent/US3939146A/en
Application filed by Strategic Medial Research Corp filed Critical Strategic Medial Research Corp
Priority to CA286,998A priority Critical patent/CA1050429A/fr
Application granted granted Critical
Publication of CA1030960A publication Critical patent/CA1030960A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA215,984A 1973-12-14 1974-12-13 Nouveau compose therapeutique et utilisation Expired CA1030960A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA286,998A CA1050429A (fr) 1973-12-14 1977-09-19 Compose therapeutique, principe actif et methode d'utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/424,786 US3939146A (en) 1973-03-01 1973-12-14 Novel ethereal monosubstitutions of monosaccharide derivatives
AU44869/79A AU533108B2 (en) 1973-12-14 1979-03-07 Etherfied monosaccharides

Publications (1)

Publication Number Publication Date
CA1030960A true CA1030960A (fr) 1978-05-09

Family

ID=25626947

Family Applications (1)

Application Number Title Priority Date Filing Date
CA215,984A Expired CA1030960A (fr) 1973-12-14 1974-12-13 Nouveau compose therapeutique et utilisation

Country Status (12)

Country Link
JP (1) JPS5619877B2 (fr)
AT (1) AT352145B (fr)
AU (1) AU533108B2 (fr)
BE (1) BE823313A (fr)
CA (1) CA1030960A (fr)
CH (1) CH606073A5 (fr)
DD (1) DD116029A5 (fr)
DE (1) DE2455026A1 (fr)
FR (1) FR2254348B2 (fr)
GB (4) GB1497406A (fr)
IN (2) IN141230B (fr)
SE (1) SE7415662L (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1227276A (en) * 1975-03-28 1977-09-29 Strategic Medical Res Corp Ethers of monosaccarides
DE3812181A1 (de) * 1988-04-13 1989-10-26 Werner E G Prof Dr Mueller Arzneimittel, enthaltend natuerliche und/oder chemisch modifizierte mono- oder polysaccharide und deren verwendung
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
US20020165168A1 (en) * 1995-12-16 2002-11-07 Joachim Bunger Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1793336C3 (de) * 1967-09-11 1974-10-03 Ciba-Geigy Ag, Basel (Schweiz) D-Glucofuranoside, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
JPS5118195B2 (fr) * 1972-06-19 1976-06-08
US3939145A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereally monosubstituted monosaccharides

Also Published As

Publication number Publication date
GB1497408A (en) 1978-01-12
FR2254348A2 (fr) 1975-07-11
AU4486979A (en) 1979-07-05
DD116029A5 (fr) 1975-11-05
GB1497407A (en) 1978-01-12
FR2254348B2 (fr) 1980-03-21
IN141230B (fr) 1977-02-05
ATA989874A (de) 1979-02-15
CH606073A5 (fr) 1978-10-13
GB1497409A (en) 1978-01-12
IN144240B (fr) 1978-04-15
AT352145B (de) 1979-09-10
JPS5093909A (fr) 1975-07-26
DE2455026C2 (fr) 1988-02-25
JPS5619877B2 (fr) 1981-05-09
GB1497406A (en) 1978-01-12
DE2455026A1 (de) 1975-07-03
AU7611374A (en) 1976-06-10
BE823313A (fr) 1975-06-13
SE7415662L (fr) 1975-06-16
AU533108B2 (en) 1983-11-03

Similar Documents

Publication Publication Date Title
CA1029153A (fr) Compose de blanchiment et mode d'emploi
CA1015954A (en) Treatment of limenite
CA1022166A (en) Therapeutic composition, novel compounds useful therein, and method of using the same
CA1033750A (fr) Derives de methyl-5 isoflavone, synthese et composes obtenus
CA1027951A (fr) Synthese de la 2,2,6,6-tetramethyle-4-oxopiperidine
CA1027950A (fr) Synthese de la 2,2,6,6-tetramethyle-4-oxopiperidine
CA994351A (en) Tetrahydronaphthyloxy-amines and related compounds
CA1027952A (fr) Synthese de la 2,2,6,6-tetramethyle-4-oxopiperidine
CA1030960A (fr) Nouveau compose therapeutique et utilisation
CA1001532A (en) Borlding compositions and methods
AU489327B2 (en) Therapeutic composition, novel compounds useful therein, and method of using thesame
AU475077B2 (en) Method and compositions for the treatment of dermatomycosis
CA1026674A (fr) Substances anesthesiques
AU476206B2 (en) Therapeutic composition
CA975976A (en) Thawer-cooker and method of using the same
CA1032529A (fr) Diethers-1,3 des azoestratrienes-2
CA1021777A (fr) Procede de synthese des 2-halogeno-5-phenyle-3h-1,4 benzodiazepines et de leurs derives
CA989157A (en) Acidizing composition
AU495749B2 (en) Therapeutic composition
AU484434B2 (en) 1, 3-diethers of 2-azaestratrienes
AU481036B2 (en) Compositions and method using nitrobenzamides
AU491398B2 (en) Hydrophalazine dertivatives and therapeutic compositions containing same
AU7277374A (en) Therapeutic composition
AU6668574A (en) Compositions and method using nitrobenzamides
AU487864B2 (en) Improved llubricant composition